Ensign Peak Advisors Portfolio holdings
AUM
$58.4B
This Quarter Return
+13.33%
1 Year Return
+23.83%
3 Year Return
+106.64%
5 Year Return
+193.2%
10 Year Return
–
AUM
$54.8B
AUM Growth
+$4.24B
(+8.4%)
Cap. Flow
-$455M
Cap. Flow
% of AUM
-0.83%
Top 10 Holdings %
Top 10 Hldgs %
29.94%
Holding
1,776
New
37
Increased
449
Reduced
1,142
Closed
51
Top Buys
| 1 |
Eli Lilly
LLY
|
$172M |
| 2 |
Uber
UBER
|
$118M |
| 3 |
Blackstone Secured Lending
BXSL
|
$103M |
| 4 |
PayPal
PYPL
|
$82.8M |
| 5 |
Amazon
AMZN
|
$82.5M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$182M |
| 2 |
Crown Castle
CCI
|
$168M |
| 3 |
CME Group
CME
|
$128M |
| 4 |
Gilead Sciences
GILD
|
$113M |
| 5 |
Amgen
AMGN
|
$111M |
Sector Composition
| 1 | Technology | 28.82% |
| 2 | Healthcare | 15.16% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
RxSight
RXST
$364M
| $361K | ﹤0.01% |
+6,997
| New | +$361K |
|
1677
Navitas Semiconductor
NVTS
$1.22B
| $350K | ﹤0.01% |
73,445
-3,705
| -5% | -$17.7K |
|
1678
Northfield Bancorp
NFBK
$497M
| $344K | ﹤0.01% |
35,413
-1,787
| -5% | -$17.4K |
|
|
RVNC
1679
DELISTED
Revance Therapeutics, Inc.
RVNC
| $331K | ﹤0.01% |
67,332
+16,982
| +34% | +$83.6K |
|
1680
Kanzhun
BZ
$11.1B
| $329K | ﹤0.01% |
18,750
| – | – |
|
1681
MarineMax
HZO
$538M
| $326K | ﹤0.01% |
9,809
+146
| +2% | +$4.86K |
|
1682
OraSure Technologies
OSUR
$230M
| $323K | ﹤0.01% |
52,519
-2,649
| -5% | -$16.3K |
|
1683
ImmunityBio
IBRX
$2.24B
| $320K | ﹤0.01% |
+59,650
| New | +$320K |
|
1684
Aurinia Pharmaceuticals
AUPH
$1.58B
| $319K | ﹤0.01% |
63,735
-3,215
| -5% | -$16.1K |
|
1685
Great Southern Bancorp
GSBC
$718M
| $316K | ﹤0.01% |
5,759
-291
| -5% | -$16K |
|
1686
Bristow Group
VTOL
$1.07B
| $315K | ﹤0.01% |
11,591
-585
| -5% | -$15.9K |
|
|
CNH
1687
CNH Industrial
CNH
$14B
| $315K | ﹤0.01% |
24,300
+5,850
| +32% | +$75.8K |
|
1688
Usana Health Sciences
USNA
$579M
| $313K | ﹤0.01% |
6,445
-325
| -5% | -$15.8K |
|
|
TBI
1689
Trueblue
TBI
$171M
| $311K | ﹤0.01% |
24,802
-1,251
| -5% | -$15.7K |
|
1690
James River Group
JRVR
$256M
| $297K | ﹤0.01% |
31,986
-1,614
| -5% | -$15K |
|
1691
Lightwave Logic
LWLG
$405M
| $297K | ﹤0.01% |
63,402
-3,198
| -5% | -$15K |
|
1692
Cassava Sciences
SAVA
$107M
| $295K | ﹤0.01% |
14,546
-734
| -5% | -$14.9K |
|
1693
Applied Digital
APLD
$3.77B
| $292K | ﹤0.01% |
+68,210
| New | +$292K |
|
1694
Forward Air
FWRD
$923M
| $285K | ﹤0.01% |
9,147
-461
| -5% | -$14.3K |
|
1695
Beyond Meat
BYND
$178M
| $280K | ﹤0.01% |
33,843
-1,707
| -5% | -$14.1K |
|
1696
Embecta
EMBC
$837M
| $267K | ﹤0.01% |
20,115
-1,015
| -5% | -$13.5K |
|
1697
Nu Skin
NUS
$596M
| $253K | ﹤0.01% |
18,326
-924
| -5% | -$12.8K |
|
1698
MaxCyte
MXCT
$147M
| $247K | ﹤0.01% |
59,013
-2,977
| -5% | -$12.5K |
|
|
PETQ
1699
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $244K | ﹤0.01% |
13,340
-630,074
| -98% | -$11.5M |
|
1700
Symbotic
SYM
$5.06B
| $234K | ﹤0.01% |
+5,203
| New | +$234K |
|